Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Clinical trial NCT03095248 · TERMINATED

Trial details

NCT number: NCT03095248
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis 2 Vestibular Schwannoma Meningioma Ependymoma Glioma

Start date: 2017-05-08
Primary completion: 2024-05-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.